Ashenafi Bulle

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer”.

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

Nature Communications(2024)10.1038/s41467-024-46811-w

N/A

0.524DataRank · unranked

32 citations

Peng Liu, Kuljeet Seehra, Sapana Bansod, Yali Chen, Kiran Zahra +22 more

Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer

Signal Transduction and Targeted Therapy(2020)10.1038/s41392-020-00341-1

N/A

0DataRank · unranked

197 citations

Kian‐Huat Lim, Ashenafi Bulle

The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS

Cell Reports(2024)10.1016/j.celrep.2024.114667

N/A

0DataRank · unranked

3 citations

Paarth B. Dodhiawala, Yutong Geng, Ashenafi Bulle, Peng Liu, Lin Li +6 more